Holocene Advisors LP Sells 452,450 Shares of Astera Labs, Inc. $ALAB

Holocene Advisors LP lessened its holdings in Astera Labs, Inc. (NASDAQ:ALABFree Report) by 73.3% during the third quarter, HoldingsChannel reports. The fund owned 164,964 shares of the company’s stock after selling 452,450 shares during the quarter. Holocene Advisors LP’s holdings in Astera Labs were worth $32,300,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Gotham Asset Management LLC acquired a new position in Astera Labs during the 3rd quarter valued at about $1,696,000. Brevan Howard Capital Management LP raised its stake in shares of Astera Labs by 151.1% in the third quarter. Brevan Howard Capital Management LP now owns 186,984 shares of the company’s stock worth $36,611,000 after purchasing an additional 112,518 shares during the last quarter. Capula Management Ltd bought a new position in shares of Astera Labs in the third quarter valued at approximately $338,000. Cinctive Capital Management LP bought a new position in shares of Astera Labs in the third quarter valued at approximately $1,842,000. Finally, Clear Street Group Inc. purchased a new position in shares of Astera Labs during the third quarter valued at approximately $60,744,000. Institutional investors own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Raymond James Financial assumed coverage on Astera Labs in a report on Friday, November 21st. They set a “hold” rating for the company. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Morgan Stanley reiterated an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a research note on Wednesday, December 3rd. Barclays set a $165.00 target price on shares of Astera Labs in a report on Thursday, January 15th. Finally, Northland Securities raised their price target on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, December 9th. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $202.22.

View Our Latest Research Report on Astera Labs

Insider Buying and Selling at Astera Labs

In other news, CEO Jitendra Mohan sold 94,971 shares of the company’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the sale, the chief executive officer directly owned 1,452,739 shares in the company, valued at $179,863,615.59. This represents a 6.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Michael Truett Tate sold 12,001 shares of the company’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total value of $1,485,843.81. Following the sale, the chief financial officer owned 192,083 shares in the company, valued at approximately $23,781,796.23. This represents a 5.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 224,292 shares of company stock worth $27,676,069 in the last three months. 12.50% of the stock is currently owned by corporate insiders.

Astera Labs Price Performance

Shares of ALAB stock opened at $127.48 on Tuesday. The stock has a market capitalization of $21.70 billion, a price-to-earnings ratio of 104.49, a PEG ratio of 2.37 and a beta of 1.75. The company’s fifty day simple moving average is $147.10 and its two-hundred day simple moving average is $167.60. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business’s revenue for the quarter was up 91.8% on a year-over-year basis. During the same period last year, the company earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities research analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

See Also

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.